Suchergebnisse - "Shi, Yuankai"

PubPharm (21)

1

Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG) : a multicentre, double-blind, randomised phase 3 study

enthalten in: The Lancet. Respiratory medicine | 2022

von Shi, Y. | Chen, G. | Wang, X. | +20

2

Central Nervous System Efficacy of Furmonertinib (AST2818) Versus Gefitinib as First-Line Treatment for EGFR-Mutated NSCLC : Results From the FURLONG Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Shi, Y. | Chen, G. | Wang, X. | +19

3

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3) : a double-blind, randomised, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Matasar, M. | Capra, M. | Özcan, M. | +27

CommentIn: Nat Rev Clin Oncol. 2021 Jun;18(6):322. - PMID 33879868

4

Clinicopathologic characteristics and outcome of patients with different EGFR mutations

enthalten in: Asia-Pacific journal of clinical oncology | 2019

von Zhou, S. | Hu, X. | Wang, Y. | +5

5

Efficacy of icotinib in lung squamous-cell cancer : A real-world experience from single institution

enthalten in: Asia-Pacific journal of clinical oncology | 2017

von Xu, J. | Liu, X. | Yang, S. | +2

6

China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2016 version)

enthalten in: Zhongguo fei ai za zhi = Chinese journal of lung cancer | 2016

von Shi, Y. | Sun, Y. | Ding, C. | +27

7

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7) : a phase 2B, open-label, randomised controlled trial

enthalten in: The Lancet. Oncology | 2016

von Park, K. | Tan, E. | O'Byrne, K. | +20

CommentIn: Lancet Oncol. 2016 May;17(5):541-3. - PMID 27301025

8

Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases

enthalten in: Zhongguo fei ai za zhi = Chinese journal of lung cancer | 2015

von Xu, J. | Liu, X. | Yang, S. | +2

9

China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2015 version)

enthalten in: Zhongguo fei ai za zhi = Chinese journal of lung cancer | 2015

von Shi, Y. | Sun, Y. | Ding, C. | +28

10

Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer : analysis of the Chinese subpopulation in the TRUST study

enthalten in: Japanese journal of clinical oncology | 2015

von Huang, Y. | Zhang, L. | Shi, Y. | +10